Bionano Genomics (BNGO) Inventory Average (2018 - 2026)

Bionano Genomics has disclosed Inventory Average across 9 years of filings, most recently posting $5.4 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $5.4 million, down 48.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (down 48.0% YoY), and the FY2025 annual result was $8.3 million, down 51.29% from the prior year.
• Inventory Average came in at $5.4 million for Q1 2026 at Bionano Genomics, down from $6.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $32.8 million in Q2 2023 to a low of $5.4 million in Q1 2026.
• The 5-year median for Inventory Average is $18.4 million (2022), against an average of $18.3 million.
• Across the five-year window, Inventory Average surged 365.04% in 2022 and slumped 53.6% in 2025, its largest moves.
• Bionano Genomics' Inventory Average stood at $27.4 million in 2022, then slipped by 10.01% to $24.7 million in 2023, then tumbled by 48.41% to $12.7 million in 2024, then tumbled by 50.88% to $6.2 million in 2025, then dropped by 13.94% to $5.4 million in 2026.
• The last three Inventory Average figures came in at $5.4 million (Q1 2026), $6.2 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.